Larvol Delta - AmMax-Bio-Announces-First-Patients-Dosed-in-Phase-2b-Study-of-AMB05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-05X - AmMax

https://www.globenewswire.com/news-release/2023/01/30/2597498/0/en/AmMax-Bio-Announces-First-Patients-Dosed-in-Phase-2b-Study-of-AMB-05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT.html

Jan 30, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next